U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  1. Drugs

Postmarket Drug Safety Information for Patients and Providers

Postmarket Drug Safety Information for Patients and Providers

In accordance with Section 915 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), this website contains links to postmarket drug safety information to improve transparency and communication to patients and healthcare providers.

Latest Safety Information

Studies and Clinical Trials of Approved Products

Risk Evaluation and Mitigation Strategies (REMS)

Registries and Clinical Trials

Information about FDA's Drug Safety Oversight Board (DSB)

General Health Information

FDA's Response to the Institute of Medicine's 2006 Report

Drug Labeling

Consumer Information

Regulations and Guidance Documents

ResourcesForYou

MedWatch